Picture of Oriola Oyj logo

ORIOLA — Oriola Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareBalancedSmall CapContrarian

Brief: Oriola Reports Q2 Sales Of EUR 51.8 Million

BRIEF-Oriola Reports Q2 Sales Of EUR 51.8 Million

- Oriola Oyj ORIOLA.HE:

  • Q2 SALES EUR 51.8 MILLION

  • Q2 EPS EUR -0.01

  • IN 2026, PHARMACEUTICAL DISTRIBUTION MARKET IS EXPECTED TO CONTINUE TO GROW

  • VALUE GROWTH IS EXPECTED TO BE DRIVEN BY HIGH-VALUE PHARMACEUTICALS AND PRODUCTS REQUIRING ADVANCED LOGISTICS.

  • FOR 2026, ORIOLA EXPECTS ADJUSTED EBITDA TO INCREASE FROM PREVIOUS YEAR

Source text: ID:nWkr7kjF3F

Further company coverage: ORIOLA.HE


(Gdansk Newsroom)

((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Oriola Oyj

See all news